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A variety of metals are essential trace elements but can reach localized toxic 
concentrations through various disease processes or environmental exposures and have been 
implicated as having a role in neurodegeneration. In particular, chronic inorganic manganese 
exposure causes selective toxicity to the nigrostriatal dopaminergic system, resulting in a 
Parkinsonian-like neurological condition known as Manganism. YPK9 gene (Yeast PARK9; also 
known as Y0R291W) encodes a transmembrane P-type transport ATPase presumably involved 
in metal coordination and transportation, though its substrate specificity still remains unknown. 
Mutations in the human homolog of YPK9, PARK9 (ATP13A2), have been linked to genetic 
forms of early onset parkinsonism. Recently a strong genetic interaction between YPK9 and 
another Parkinson's disease protein, a-synuclein, has been evidenced in multiple model systems, 
indicating a crucial role for YPK9 in manganese detoxification in yeast and a specific protecting 
effect against manganese poisoning [1,3]. 
With the purpose to shed light on the protective property of YPK9 in Manganese-induced 
Parkinsonism, we tested the binding ability of Mn(II) and other divalent cations (Cu(II), Zn(II» 
towards several peptide sequences from YPK9, with a particular focus on highly conserved 
sequences from yeast to human. The work was carried out at different pH values and 
ligand/metal molar ratios by means of potentiometric and spectroscopic techniques 
(multidimensional and heteronuclear NMR and UV-visible), in order to evaluate and compare 
the coordination propensity of such fragments with Mn(II) and the other metal probes selected 
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Figure 1. The model of the YPK9 protein 
built with ESyPred3D using the 3D crystal 
structure of the sodium-potassium pump 
(PDB 3B8E chain A) as the template, and the 
3D structural models proposed for the Mn(II) 
ion complexed with selected fragments of 
YPK9 protein sequence. 
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